NCT01966679View on ClinicalTrials.gov

Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Autism Spectrum Disorder
Interventions
DRUG

AZD7325

DRUG

Placebo

Trial Locations (3)

90095

UCLA, Los Angeles

98121

Seattle Children's Research Institute, Seattle

Unknown

Emory University, Atlanta

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT01966679 - Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial | Biotech Hunter | Biotech Hunter